GW Center for Integrative Medicine
- IV Therapy
- Ketamine Therapy
- Hormone Replacement Therapy (HRT)
Read the Ketamine Therapy guide for the educational context behind this treatment category.
District of Columbia
Ketamine therapy in Washington, DC is available within the District of Columbia, alongside a wider regional network in Maryland and Northern Virginia. This listing covers the whole District, which sits within a single metropolitan area. Nearby options include Bethesda, Rockville, and McLean, but those addresses fall outside DC. Check the treatment location before comparing providers: a Washington-area search result may involve crossing a jurisdictional boundary for every appointment.
For anyone traveling from farther into Maryland or Virginia, the practical question is whether the trip works for assessment, treatment, and follow-up. Allow for monitoring and recovery as well as travel, and arrange the return trip with a responsible adult according to the provider's discharge instructions. Do not plan to drive yourself home after treatment.
DC care falls under federal medication rules and District professional licensing. Medical offices and infusion suites provide monitored treatment; a wellness description alone tells you little about the clinical arrangements. Ask who prescribes, who administers the medication, who supervises care, and who handles an emergency. IV ketamine for depression is off label, meaning it is not FDA approved for that use; nasal esketamine has specific approved depression uses and separate monitoring requirements.
Check physicians and physician assistants through the District of Columbia Board of Medicine, and nurses, including nurse practitioners, through the District of Columbia Board of Nursing. Review license status and public disciplinary orders, then ask about experience treating your condition. Licensing records do not establish whether a particular treatment will help you.
Before booking, request the medication name, route, source, and written risk disclosures. Ask how progress is assessed and what happens if treatment does not help. Most IV ketamine care for depression is cash pay, so request a quote separating evaluation, medication, monitoring, psychotherapy, and follow-up.
Regenerated.com is free for patients, and organic listing order is not sold. Featured slots are labeled and capped. Verified means credential checks, not spending, and directory inclusion is not an endorsement.
The national ketamine therapy hub explains the mechanism, evidence, and remaining uncertainties. For help interpreting these listings, read How to read a Regenerated city hub and Featured vs Verified vs organic.
Regulatory context
Ketamine is a DEA Schedule III controlled substance, FDA-approved as a dissociative anesthetic and used off-label for treatment-resistant depression, PTSD, and chronic pain. The FDA approved esketamine (Spravato) in 2019 for treatment-resistant depression under a Risk Evaluation and Mitigation Strategy (REMS) program that requires in-office administration at certified sites. MDMA-assisted therapy remains Schedule I; the FDA issued a Complete Response Letter in August 2024 to Lykos Therapeutics on its MDMA new drug application. Psilocybin is Schedule I and holds FDA Breakthrough Therapy designation through sponsors such as Compass Pathways and Usona, but has not received FDA approval. Oregon Measure 109 (passed 2020, operational 2023) created a state psilocybin service center framework, and Colorado Proposition 122 (2022) authorized regulated healing centers.
DC's Initiative 81 deprioritizes MPD enforcement against natural psychedelics but federal law applies fully on federal property (much of DC). The DC Board of Medicine oversees prescriber conduct. DEA enforcement on ketamine clinics focuses on diversion and Ryan Haight Act telehealth rules. Federal jurisdiction in DC adds enforcement complexity compared to states.
Explore by location
More in this state
Nationwide
Ketamine Therapy clinics across the US